Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0001856094-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | 2025-12-02 | RXRX | Borgeson Blake | Dir | S - Sale | $4.37 | -220.0K | 6.87M | -3% | -$961.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-02 | S | D | 220,000 | $4.37 | 6,869,863 | D | — | — |